Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblastsBenjamin P. Sharpe, Tim Underwood|Cell Reports Medicine|2022Cited by 24
Patient-derived tumor organoid and fibroblast assembloid models for interrogation of the tumor microenvironment in esophageal adenocarcinomaBenjamin P. Sharpe, Tim Underwood|Cell Reports Methods|2024Cited by 10